Rifampicin Price ($RIF)
Rifampicin Price ($RIF)
1 $RIF to USD Live Price:
Rifampicin Price Today
The live Rifampicin ($RIF) price today is $ 0.00061863, with a 2.54% change over the past 24 hours. The current $RIF to USD conversion rate is $ 0.00061863 per $RIF.
Rifampicin currently ranks #- by market capitalization at $ 618,426, with a circulating supply of 999.66M $RIF. During the last 24 hours, $RIF traded between $ 0.00058665 (low) and $ 0.00063563 (high), reflecting market activity. Its all-time high stands at $ 0.247831, while the all-time low was $ 0.00058665.
In short-term performance, $RIF moved -0.64% in the last hour and -18.01% over the past 7 days. Over the past day, total trading volume reached --.
Rifampicin ($RIF) Market Information
The current Market Cap of Rifampicin is $ 618.43K, with a 24-hour trading volume of --. The circulating supply of $RIF is 999.66M, with a total supply of 999655351.8. Its Fully Diluted Valuation (FDV) is $ 618.43K.
Rifampicin Price History USD
-0.64%
-2.54%
-18.01%
-18.01%
Rifampicin ($RIF) Price History USD
During today, the price change of Rifampicin to USD was $ 0.
In the past 30 days, the price change of Rifampicin to USD was $ -0.0002643046.
In the past 60 days, the price change of Rifampicin to USD was $ -0.0004225343.
In the past 90 days, the price change of Rifampicin to USD was $ 0.
| Period | Change (USD) | Change (%) |
|---|---|---|
| Today | $ 0 | -2.54% |
| 30 Days | $ -0.0002643046 | -42.72% |
| 60 Days | $ -0.0004225343 | -68.30% |
| 90 Days | $ 0 | -- |
Price Prediction for Rifampicin
In 2040, the price of Rifampicin could potentially see a growth of 0.00%. It could reach a trading price of $ --.
For real-time scenario projections and a more personalized analysis, users can utilize MEXC's Price Prediction Tool and AI Market Insights.
Want to know what price Rifampicin will reach in 2025–2026? Visit our Price Prediction page for $RIF price predictions for the years 2025–2026 by clicking Rifampicin Price Prediction.
What is Rifampicin ($RIF)
$RIF token represents longevity experiments performed with the compound Rifampicin. These experiments are live-streamed on Pump Science.
What is Pump Science? Pump Science is a gamified longevity research platform. Users can speculate on life-extending compounds, stream live experiment data, and submit your own longevity cocktails for testing on model organisms.
What is Rifampicin? Rifampicin is traditionally known as an antibiotic, but it’s been gaining attention for its surprising effects on aging. In tiny organisms like C. elegans (a model organism often used in aging research), Rifampicin has been shown to activate the cell’s natural defense mechanisms against stress and damage. Imagine it as a sort of "cellular coach," encouraging cells to stay healthy and resilient by protecting against harmful oxidative stress and maintaining the quality of proteins within the cell. These protective effects help the worms live longer and healthier lives. While it’s still early days, and we don’t yet know if Rifampicin can do the same in humans, its ability to promote cellular health makes it an exciting area of research in the quest for anti-aging therapies.
MEXC is the leading cryptocurrency exchange trusted by over 10 million users worldwide. It is renowned as the exchange with the widest token selection, the fastest token listings, and the lowest trading fees in the market. Join MEXC now to experience top-tier liquidity and the most competitive fees in the market!
People Also Ask: Other Questions About Rifampicin
Rifampicin ($RIF) Important Industry Updates
| Time (UTC+8) | Type | Information |
|---|---|---|
| 11-17 11:15:44 | Industry Updates | Cryptocurrency "Bear Market" Intensifies, Bitcoin Erases Year-to-Date Gains, Ethereum Barely Holds $3,000 |
| 11-17 03:26:00 | Industry Updates | U.S. Ethereum Spot ETFs See Net Outflows of $728.3 Million This Week |
| 11-16 23:43:30 | Industry Updates | Bitcoin's November return this year is temporarily reported at -12.39%, compared to the historical average return of 42.49% |
| 11-16 18:32:59 | Industry Updates | SOL spot ETF records net inflows for 14 consecutive trading days, with total inflows reaching $382 million |
| 11-16 05:28:58 | Industry Updates | The total market value of stablecoins decreased by 0.41% over the past 7 days, falling to $304.2 billion |
| 11-15 14:42:25 | Industry Updates | Privacy sector tokens show widespread gains, DASH up 41.6%, ZEC rebounds to $743 |
Explore More about Rifampicin
More Cryptocurrencies to Explore
Top cryptocurrencies with market data available on MEXC
HOT
Currently trending cryptocurrencies that are gaining significant market attention
Newly Added
Recently listed cryptocurrencies that are available for trading
Top Gainers
Today's top crypto pumps
DramaBits
DRAMA
+689.65%
BNBird
BIRD
+315.38%
DEGENFI
DEGENFI
+69.18%
The Official 67 Coin
67
+43.31%
Notevia
NVA
+36.95%
Disclaimer
Cryptocurrency prices are subject to high market risks and price volatility. You should invest in projects and products that you are familiar with and where you understand the risks involved. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material should not be construed as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. MEXC is not responsible for any losses you may incur. For more information, please refer to our Terms of Use and Risk Warning. Please also note that data relating to the above-mentioned cryptocurrency presented here (such as its current live price) are based on third party sources. They are presented to you on an “as is'' basis and for informational purposes only, without representation or warranty of any kind. Links provided to third-party sites are also not under MEXC’s control. MEXC is not responsible for the reliability and accuracy of such third-party sites and their contents.